BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation named senior executive Steven Rosenberg Chief Operating Officer. PHT is the leading provider of innovative technology systems used to collect patient-driven eData for clinical research.
Steve will have responsibility for all aspects of Product Development, Product Management and Service Delivery.
PHT President and CEO Philip Lee said, "I am thrilled to welcome Steve to the PHT Leadership Team. Steve has more than 30 years of experience in operations at some of the most successful Boston-area high tech companies. PHT has a tremendous opportunity for rapid growth in the coming years as trial sponsors rapidly adopt electronic systems to replace outdated paper processes and move to more patient-centric research models. Steve is extremely familiar with the eClinical industry and understands the critical role technology systems play in clinical research."
Steve Rosenberg said, "PHT is a leader in eClinical systems with a reputation for delivering products that accelerate clinical development and support new drug application approvals. PHT has a platform for numerous market expansion opportunities and is positioned for rapid and profitable growth. I am eager to contribute my experience to PHT and help bring the company to the next level of operational excellence and customer satisfaction." Steve discusses his decision to join PHT and the company's market leadership in advancing eClinical research: http://bit.ly/11QnqX5
Steve was previously Vice President of Software and Services, Health Sciences Global Business Unit (HSGBU) at Oracle Corporation where he led 1,100 professionals and directed all aspects of product development, services, support, and hosting (SAAS services) for HSGBU Oracle and Phase Forward products.
Prior to Oracle, Steve was Senior Vice President of Software and Services for Phase Forward, where he led all product development, global services, hosting, Helpdesk and Information Technology. Steve was involved in all acquisitions from identification to integration. He was instrumental in the company's success including the 2004 IPO and 2010 $685 million sale to Oracle.
About PHT Corporation
PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT eCOA (electronic Clinical Outcome Assessment) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via the PHT StudyWorks® online portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 600+ global trials resulting in 16 regulatory approvals. PHT offers the regulatory, technological, and scientific expertise today's market demands and patients deserve. Visit www.phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter and YouTube.
For PHT Corporation
Brenda Nashawaty, 617-688-3253